Evaluation of anti-factor VIII antibodies in haemophilia A subjects switching products following a provincial tender

Haemophilia. 2022 Jan;28(1):e1-e4. doi: 10.1111/hae.14434. Epub 2021 Nov 11.
No abstract available

Keywords: bleeds; factor VIII usage; haemophilia A; inhibitor; recombinant factor VIII; switching products.

Publication types

  • Letter

MeSH terms

  • Antibodies
  • Factor VIII
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • Antibodies
  • Factor VIII